The good news is that the landscape of options has expanded dramatically
Serious adverse events (pancreatitis, gallbladder issues, hypoglycemia in diabetic patients) are documented in trials and apply to both forms
Pharma Industry 4 min read GLP-1 drugs may have a beneficial effect across many types of cancer More than two dozen studies presented over the past few days at the American Society of Clinical Oncology meeting in Chicago found that patients taking the drugs showed lower risks of developing cancer and disease progression, better survival, and improved responses to some treatments, compared with people who were not taking the GLP-1s
Common side effects include nausea, vomiting, diarrhoea, and constipation consistent with the known GLP-1 receptor agonist class profile
Download the full HPLC and Mass Spectrometry reports for the current batch #88291
Many providers consider it the next evolution of GLP-1 therapy